Prosecution Insights
Last updated: April 19, 2026

Revival Animal Health LLC

5 pending office actions

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18909731 SYSTEM AND METHOD FOR AGGREGATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS CLARKE, TRENT R 1651 Non-Final OA Oct 08, 2024
18909762 SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS CLARKE, TRENT R 1651 Non-Final OA Oct 08, 2024
18424552 SYSTEM AND METHOD FOR ALLOGENEIC OR XENOGENEIC USE OF ALPHA 2M MOLECULES IN TREATING MEDICAL CONDITIONS CLARKE, TRENT R 1651 Non-Final OA Jan 26, 2024
18535841 SYSTEM AND METHOD FOR ISOLATION AND AUTOLOGOUS USE OF ALPHA 2M MOLECULES TO TREAT RESPIRATORY CONDITIONS CLARKE, TRENT R 1651 Non-Final OA Dec 11, 2023
18215498 SYSTEM AND METHOD FOR ISOLATING ALPHA 2M MOLECULES CLARKE, TRENT R 1651 Non-Final OA Jun 28, 2023

Managing Revival Animal Health LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month